Conformationally restricted (+)-cacospongionolide B analogues.: Influence on secretory phospholipase A2 inhibition

被引:13
|
作者
Murelli, Ryan P. [1 ]
Cheung, Atwood K. [1 ]
Snapper, Marc L. [1 ]
机构
[1] Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA
来源
JOURNAL OF ORGANIC CHEMISTRY | 2007年 / 72卷 / 05期
关键词
D O I
10.1021/jo061407a
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
A new approach to (+)-cacospongionolide was developed to access conformationally restricted variants of the natural product. The flexible aliphatic region between the decalin and side chain portion of the natural product was replaced with alkenyl and alkynyl linkers to probe the influence of structural rigidity in the inhibition of secretary phospholipase A(2) (sPLA(2)). It was found that when the aliphatic section is replaced with a Z-olefin or an alkyne, sPLA(2) inhibitory activity suffered relative to the natural product; however, an E-olefin-containing analogue led to an enhanced activity. These results suggest that preferred sPLA(2) binding conformation of the natural product is similar to the geometry of the E-olefin-containing analogue.
引用
收藏
页码:1545 / 1552
页数:8
相关论文
共 50 条
  • [1] Total syntheses of (+)- and (-)-cacospongionolide B, cacospongionolide E, and related analogues.: Preliminary study of structural features required for phospholipase A2 inhibition
    Cheung, AK
    Murelli, R
    Snapper, ML
    JOURNAL OF ORGANIC CHEMISTRY, 2004, 69 (17): : 5712 - 5719
  • [2] Total syntheses of (+)- and (-)-cacospongionolide B:: New insight into structural requirements for phospholipase A2 inhibition
    Cheung, AK
    Snapper, ML
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (39) : 11584 - 11585
  • [3] Secretory phospholipase A2
    Murakami, M
    Kudo, I
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2004, 27 (08) : 1158 - 1164
  • [4] Inhibition of secretory Phospholipase A2 Group IIa by thyroid hormone
    Sharma, Pragya
    Thakran, Shalini
    Deng, Xiong
    Elam, Marshall B.
    Park, Edwards A.
    FASEB JOURNAL, 2013, 27
  • [5] Secretory phospholipase A2 in pRBCs
    Cardo, L. J.
    Swingholm, M.
    TRANSFUSION, 2007, 47 (03) : 94A - 94A
  • [6] A new cacospongionolide inhibitor of human secretory phospholipase A2 from the Tyrrhenian sponge Fasciospongia cavernosa and absolute configuration of cacospongionolides
    De Rosa, S
    Crispino, A
    De Giulio, A
    Iodice, C
    Benrezzouk, R
    Terencio, MC
    Ferrándiz, L
    Alcaraz, MJ
    Payá, M
    JOURNAL OF NATURAL PRODUCTS, 1998, 61 (07): : 931 - 935
  • [7] Biology of Secretory Phospholipase A2
    Boyanovsky, Boris B.
    Webb, Nancy R.
    CARDIOVASCULAR DRUGS AND THERAPY, 2009, 23 (01) : 61 - 72
  • [8] Biology of Secretory Phospholipase A2
    Boris B. Boyanovsky
    Nancy R. Webb
    Cardiovascular Drugs and Therapy, 2009, 23
  • [9] Phospholipase A2 receptor:: a regulator of biological functions of secretory phospholipase A2
    Hanasaki, K
    Arita, H
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2002, 68-9 : 71 - 82
  • [10] Nonantibiotic Properties of Tetracyclines: Structural Basis for Inhibition of Secretory Phospholipase A2
    Dalm, Daniela
    Palm, Gottfried J.
    Aleksandrov, Alexey
    Simonson, Thomas
    Hinrichs, Winfried
    JOURNAL OF MOLECULAR BIOLOGY, 2010, 398 (01) : 83 - 96